Skip Nav Destination
Issues
15 August 2002
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Advances in Brief
Few FH Mutations in Sporadic Counterparts of Tumor Types Observed in Hereditary Leiomyomatosis and Renal Cell Cancer Families1
Maija Kiuru; Rainer Lehtonen; Johanna Arola; Reijo Salovaara; Heikki Järvinen; Kristiina Aittomäki; Jari Sjöberg; Tapio Visakorpi; Sakari Knuutila; Jorma Isola; Brett Delahunt; Riitta Herva; Virpi Launonen; Auli Karhu; Lauri A. Aaltonen
Cyclin D1 Is Not an Essential Target of β-Catenin Signaling During Intestinal Tumorigenesis, but It May Act as a Modifier of Disease Severity in Multiple Intestinal Neoplasia (Min) Mice1
Jenny Wilding; Josef Straub; Julie Bee; Michael Churchman; Walter Bodmer; Clive Dickson; Ian Tomlinson; Mohammad Ilyas
Biochemistry and Biophysics
Carcinogenesis
CBFA2T3 (MTG16) Is a Putative Breast Tumor Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 16q24.31
Marina Kochetkova; Olivia L. D. McKenzie; Anthony J. Bais; Julie M. Martin; Genevieve A. Secker; Ram Seshadri; Jason A. Powell; Susan J. Hinze; Alison E. Gardner; Hayley E. Spendlove; Nathan J. O’Callaghan; Anne-Marie Cleton-Jansen; Cees Cornelisse; Scott A. Whitmore; Joanna Crawford; Gabriel Kremmidiotis; Grant R. Sutherland; David F. Callen
Clinical Investigations
Enhanced Benefit from Adjuvant Chemotherapy in Breast Cancer Patients Classified High-Risk according to Urokinase-type Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor Type 1 (n = 3424)1
Nadia Harbeck; Ronald E. Kates; Maxime P. Look; Marion E. Meijer-van Gelder; Jan G. M. Klijn; Achim Krüger; Marion Kiechle; Fritz Jänicke; Manfred Schmitt; John A. Foekens
Endocrinology
Oxytocin Synthesis and Oxytocin Receptor Expression by Cell Lines of Human Small Cell Carcinoma of the Lung Stimulate Tumor Growth through Autocrine/Paracrine Signaling1
Christel Péqueux; Christophe Breton; Jean-Claude Hendrick; Marie-Thérèse Hagelstein; Henri Martens; Rosita Winkler; Vincent Geenen; Jean-Jacques Legros
Epidemiology and Prevention
Experimental Therapeutics
ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration
Stephen R. Wedge; Donald J. Ogilvie; Michael Dukes; Jane Kendrew; Rosemary Chester; Janet A. Jackson; Sarah J. Boffey; Paula J. Valentine; Jon O. Curwen; Helen L. Musgrove; George A. Graham; Gareth D. Hughes; Andrew P. Thomas; Elaine S. E. Stokes; Brenda Curry; Graham H. P. Richmond; Peter F. Wadsworth; Alison L. Bigley; Laurent F. Hennequin
Treatment of Cancer Cells with Methioninase Produces DNA Hypomethylation and Increases DNA Synthesis1
David Machover; Jacqueline Zittoun; Raphaël Saffroy; Philippe Broët; Stéphane Giraudier; Thierry Magnaldo; Emma Goldschmidt; Brigitte Debuire; Mireille Orrico; Yuying Tan; Zohar Mishal; Odile Chevallier; Carole Tonetti; Hélène Jouault; Ayhan Ulusakarya; Marie-Laure Tanguy; Gérard Metzger; Robert M. Hoffman
Immunology
Molecular Biology and Genetics
Gene Expression in Ovarian Cancer Reflects Both Morphology and Biological Behavior, Distinguishing Clear Cell from Other Poor-Prognosis Ovarian Carcinomas1
Donald R. Schwartz; Sharon L. R. Kardia; Kerby A. Shedden; Rork Kuick; George Michailidis; Jeremy M. G. Taylor; David E. Misek; Rong Wu; Yali Zhai; Danielle M. Darrah; Heather Reed; Lora H. Ellenson; Thomas J. Giordano; Eric R. Fearon; Samir M. Hanash; Kathleen R. Cho
Tumor Biology
Letters to the Editor
Advertisement
